Clinical trial
Ologen (OculusGen)-Glaucoma Case Control Trial in India
NCT00448929 · Pro Top & Mediking Company Limited, Industry · Completed
Key facts
| NCT number | NCT00448929 |
|---|---|
| Title | Ologen (OculusGen)-Glaucoma Case Control Trial in India |
| Official title | Comparative Study of the Safety and Effectiveness Between Trabeculectomy and Trabeculectomy With Ologen (OculusGen) Collagen Matrix Implant |
| Lead sponsor | Pro Top & Mediking Company Limited, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Glaucoma |
| Intervention type | Device |
| Interventions | OculusGen Biodegradable Collagen Matrix Implant |
| Enrollment | 40 |
| Start date | Jan 1, 2007 |
| Primary completion | Oct 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | Mar 19, 2007 |
| Last update posted | Jun 27, 2017 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: